Keyphrases
Cyclin-dependent Kinase 4 (CDK4)
100%
Kinetochore
92%
Mitotic Checkpoint
71%
Overgrowth
63%
Phosphatase
62%
Protein Phosphatase 2A (PP2A)
57%
Polo-like Kinase 1 (PLK1)
53%
Replication Stress
42%
Spindle Assembly Checkpoint
40%
Oncogenic Signaling
35%
G1 Cell Cycle Arrest
35%
Cancer Cells
35%
PP2A-B56
35%
Bifunctional
35%
KNL1
35%
Mitosis
33%
Cell Cycle Exit
33%
G1 Arrest
31%
Error Correction
30%
Senescence
29%
Microtubule Attachment
25%
Cell Growth
24%
Tumor Cells
19%
Osmotic Stress
17%
Division of Labor
17%
P38 Activation
17%
Mad1
17%
Mitotic Fidelity
17%
Mitotic Errors
17%
Centromere
17%
Osmotic Stress Response
17%
Corona
17%
Proliferation Assay
17%
Cyclin B1
17%
Sigma Phase
15%
Genome Stability
14%
Phosphorylation
14%
DNA Damage
13%
Chromosome Segregation Errors
12%
Mitotic Processes
12%
Chromosome Segregation
12%
In Cancer
11%
Tumor Subtype
11%
Cell Size
10%
Binding Motif
10%
Palbociclib
10%
HER2 Breast Cancer
9%
Chromosome Movement
8%
Network Hubs
8%
SGO2
8%
Rapid Response
8%
Attachment Strength
8%
Signaling Network
8%
Changing Conditions
8%
Deactivation
8%
Specific Interactions
8%
BubR1
8%
Spatiotemporal Control
8%
Microtubules
8%
Genotoxic Damage
8%
Maximal Strength
8%
Excessive Growth
8%
Mitotic Delay
8%
Negative Feedback
8%
Transformed Cells
8%
Attachment Process
8%
Healthy Tissue
8%
Mammalian Target of Rapamycin (mTOR)
8%
Serine/threonine Protein Phosphatase
8%
Phosphatase Regulation
7%
Dephosphorylation
7%
ER +
7%
Anticancer Drugs
7%
Long-lasting Effect
6%
Tumor Growth
6%
DNA Replication
5%
Breast Cancer
5%
Clinical Trials
5%
DepMap
5%
Knockdown
5%
Cyclin D1 (CCND1)
5%
Biochemistry, Genetics and Molecular Biology
Kinetochore
96%
Cell Cycle
95%
Spindle Checkpoint
83%
G1/S Transition
66%
Phosphatase
66%
Cancer Cell
35%
PLK1
35%
Cell Growth
35%
P21
29%
Chromosome Segregation
26%
Kinase
26%
Phosphotransferase
26%
DNA Damage
21%
Osmotic Stress
20%
Dynamics
19%
S Phase
18%
Centromere
17%
MAD1
17%
Isoform
17%
Adenosine Triphosphate
17%
Cyclin B1
17%
Polo-Like Kinase 1
17%
Mitosis Inhibition
14%
Genome Instability
14%
Clinical Trial
13%
Mammalian Target of Rapamycin
12%
Tumor Progression
11%
P53
10%
Cell Size
8%
Mitochondrion
8%
Cell Cycle Arrest
8%
Cyclin D1
8%
Cyclin E1
8%
DNA Synthesis
8%
Cell Cycle Checkpoint
8%
Cyclin-Dependent Kinase
8%
Product Inhibition
7%
Serine
6%
Threonine
6%
Dephosphorylation
5%